Trial Profile

A Randomised, Open-Label, Assessor-Blind, Parallel Groups, Multicentre Trial Comparing the Efficacy of MENOPUR Versus Recombinant FSH in Controlled Ovarian Stimulation Following a GnRH Antagonist Protocol and Single Embryo Transfer

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 07 Oct 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Menotropin (Primary) ; Choriogonadotropin alfa; Follitropin beta; Ganirelix; Gonadotropins; Progesterone
Indications Female infertility
Focus Therapeutic Use
Acronyms MEGASET
Sponsors Ferring Pharmaceuticals

19 Apr 2012 Actual patient number changed from (754) to (749) as reported by ClinicalTrials.gov.
19 Apr 2012 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
19 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com